Efrat Flashner-Abramson
Impact in
-
- Cancer, Hypoxia, and Metabolism
-
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Cytokine Signaling Pathways and Interactions
Papers in
-
- Bioinformatics and Genomic Networks 6
- Melanoma and MAPK Pathways 2
- RNA Interference and Gene Delivery 2
- Oncology 4
- Cytokine Signaling Pathways and Interactions 2
- HER2/EGFR in Cancer Research 2
- Co-authors
- Alexander Levitzki (6 shared papers)Michael Karin (1 shared paper)Elsa Sánchez‐López (1 shared paper)Koji Taniguchi (1 shared paper)Shabnam Shalapour (1 shared paper)Zhenyu Zhong (1 shared paper)Alexei Shir (3 shared papers)Menashe Bar‐Eli (2 shared papers)
- Journals
- Theranostics (2 papers)Oncogene (2 papers)Proceedings of the National Academy of Sciences (2 papers)Molecular Cancer Therapeutics (1 paper)Biomolecules (1 paper)
- Partner nations
- IsraelUnited StatesAustralia
In The Last Decade
Efrat Flashner-Abramson
13 papers receiving 387 citations
Peers
Comparison fields: 5 of 66
- Cancer Research 97
- Oncology 150
- Immunology 73
- Molecular Biology 230
- Aging 5
Countries citing papers authored by Efrat Flashner-Abramson
This map shows the geographic impact of Efrat Flashner-Abramson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Efrat Flashner-Abramson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Efrat Flashner-Abramson more than expected).
Fields of papers citing papers by Efrat Flashner-Abramson
This network shows the impact of papers produced by Efrat Flashner-Abramson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Efrat Flashner-Abramson. The network helps show where Efrat Flashner-Abramson may publish in the future.
Co-authors
The 25 scholars most cited alongside Efrat Flashner-Abramson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 131 | |
| 2 | 2013 | 101 | |
| 3 | 2015 | 35 | |
| 4 | 2019 | 29 | |
| 5 | 2021 | 17 | |
| 6 | 2018 | 14 | |
| 7 | 2022 | 14 | |
| 8 | 2018 | 14 | |
| 9 | 2022 | 11 | |
| 10 | 2017 | 10 | |
| 11 | 2018 | 7 | |
| 12 | 2020 | 5 | |
| 13 | 2017 | 5 |
About Efrat Flashner-Abramson
Efrat Flashner-Abramson is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Computational Theory and Mathematics and Immunology, having authored 13 papers that have together received 393 indexed citations. Recurring topics across this work include Bioinformatics and Genomic Networks (6 papers), Computational Drug Discovery Methods (3 papers), Cytokine Signaling Pathways and Interactions (2 papers), Cancer Genomics and Diagnostics (2 papers), Melanoma and MAPK Pathways (2 papers), Immunotherapy and Immune Responses (2 papers), HER2/EGFR in Cancer Research (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Cancer Research (97 citations), Oncology (150 citations), Immunology (73 citations), Molecular Biology (230 citations) and Aging (5 citations). Efrat Flashner-Abramson has collaborated with scholars based in Israel, United States and Australia. Frequent co-authors include Alexander Levitzki, Michael Karin, Elsa Sánchez‐López, Koji Taniguchi, Shabnam Shalapour, Zhenyu Zhong, Alexei Shir, Menashe Bar‐Eli, Hadas Reuveni and Nataly Kravchenko‐Balasha. Their work appears in journals such as Theranostics, Oncogene, Proceedings of the National Academy of Sciences, Molecular Cancer Therapeutics and Biomolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.